Form 4: Health Catalyst CEO Sells Shares for Tax Obligations

Health Catalyst CEO Daniel D. Burton sold 8,335 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Summary

• Daniel D. Burton, Chief Executive Officer and Director of Health Catalyst, Inc. (HCAT), reported a transaction involving the company's common stock.
• On September 2, 2025, Mr. Burton disposed of 8,335 shares of common stock at a price of $3.3627 per share.
• This sale was a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• The transaction does not represent a discretionary trade by Mr. Burton.
• Following this transaction, Mr. Burton beneficially owns 1,448,814 shares of Health Catalyst, Inc. common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a non-discretionary 'sell to cover' for tax purposes, which is a routine event for executives receiving equity compensation and does not reflect a change in management's outlook on the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units.
• This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: Minimal impact as the transaction is a routine, non-discretionary sale for tax purposes and does not signal a change in the CEO's confidence or the company's fundamentals.

Key Dates

Recommendation

The reported transaction is a mandatory 'sell to cover' to satisfy tax obligations related to vested Restricted Stock Units, not a discretionary sale. As such, it does not provide new information that would alter the fundamental investment thesis for Health Catalyst, Inc., warranting a 'hold' recommendation based solely on this filing.

Keywords

HCAT, Health Catalyst, Insider Transaction, Form 4, Daniel Burton, CEO, Stock Sale, Restricted Stock Units, Tax Withholding